Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
05/1989
05/09/1989CA1253997A1 Process for purifying growth hormone-like materials
05/09/1989CA1253856A1 Brain-specific drug delivery
05/09/1989CA1253816A1 Monoclonal antibodies against alveolar surfactant protein
05/09/1989CA1253800A1 Human suppressor factor(s) and method
05/05/1989WO1989003996A1 Human gamma, delta t cell antigen receptor polypeptides and nucleic acids
05/05/1989WO1989003993A1 Paired helical filament core and antibody thereto useful in diagnosing alzheimer's disease
05/05/1989WO1989003887A1 A process for the production of biologically active peptide via the expression of modified storage seed protein genes in transgenic plants
05/05/1989WO1989003886A1 Expression systems for preparation of polypeptides in prokaryotic cells
05/05/1989WO1989003884A1 Interleukin-7
05/05/1989WO1989003883A1 Enhancement of cell growth by expression of a cloned hemoglobin gene
05/05/1989WO1989003881A1 Nonglycosylated analogs of human colony stimulating factors
05/05/1989WO1989003880A1 A gene coding for glucuronide permease
05/05/1989WO1989003878A1 Defective recombinant gene which can be activated by a transactivator
05/05/1989WO1989003874A1 Novel polypeptide compounds
05/05/1989WO1989003873A1 Regulation of cell proliferation and differentiation using peptides
05/05/1989WO1989003872A1 Generation of neural precursor cell lines
05/05/1989WO1989003849A1 Oligonucleotide-polyamide conjugates
05/05/1989WO1989003846A2 Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
05/05/1989WO1989003845A1 Ps2 protein derivative
05/05/1989WO1989003844A1 Hiv peptides, artificial hiv antigens and immunoassay kits
05/05/1989WO1989003842A1 Renin inhibitors containing a (1-amino-2-hydroxy-2-heterocyclic) ethyl moiety
05/05/1989WO1989003841A1 Renin inhibitors, processes for preparing them, methods for using them, and compositions containing them
05/05/1989WO1989003840A1 Method of purifying protein
05/05/1989WO1989003836A1 Factors associated with essential hypertension
05/05/1989WO1989003813A1 Anti-retroviral agent
05/05/1989WO1989003690A1 Application of dinitro-trinitrophenyl and its derivatives or of anti-nitrophenyl antibodies to the modification of the interaction between the target cellules of a host and a pathogenic agent
05/05/1989WO1989003687A1 Composition and method for treating cancers characterized by over-expression of the c-fms proto-oncogene
05/05/1989WO1989003686A1 Cgrp for cerebral blood supply improvement
05/05/1989WO1989003680A1 Conjugates between a drug and a nitrophenyl group and their pharmaceutical application
05/03/1989EP0314580A1 Use of nitrophenyl groups for stimulating the capability of incorporation of a drug into the sensitive cells of a host
05/03/1989EP0314576A1 Tetra and pentapeptides with the sequence lysyl-arginyl-aspartyl, and their use as antithrombotics
05/03/1989EP0314569A1 Recombinant fowlpox virus, expression vectors for heterologous proteins, and vaccines for fowl derived from this virus
05/03/1989EP0314534A1 Expression vector for proteins from the HIV-2 virus, one of the agents that cause AIDS
05/03/1989EP0314415A2 Interleukin-7
05/03/1989EP0314402A2 Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
05/03/1989EP0314317A1 Adheson variants, nucleic acid encoding them and compositions comprising them
05/03/1989EP0314240A2 Process for purifying recombinant hepatitis antigens
05/03/1989EP0314239A2 Tripeptide renin inhibitors with N-terminal ureido or sulfamido groups
05/03/1989EP0314224A1 Vaccine against E.coli septicaemia in poultry
05/03/1989EP0314202A1 The isolation of mRNA
05/03/1989EP0314184A1 Expression plasmids
05/03/1989EP0314127A2 Heterobifunctional coupling agents
05/03/1989EP0314095A1 Plasma and recombinant protein formulation in high ionic strength media
05/03/1989EP0314094A2 Recombinant lymphotoxin
05/03/1989EP0314060A2 Renin inhibitors, processes for preparing them, methods for using them, and compositions containing them
05/03/1989EP0314023A2 Peptides containing glutamine, process for their preparation and their use
05/03/1989EP0313969A2 Tripeptide derivatives and antiplasmin agents containing the same
05/03/1989EP0313874A2 Disulfur analogs of LL-E33288 antitumor agents
05/03/1989EP0313873A1 Targeted forms of methyltrithio antitumor agents
05/03/1989EP0313641A1 Activation antigen
05/03/1989DE3833897A1 Klonierung und expression des transforming growth faktor-(beta)2 Cloning and expression of transforming growth factor (beta) 2
05/03/1989CN1032661A Method of purifying protein
05/02/1989US4826957 Immunogenic recombinant yeast expression product and method for purifying it
05/02/1989US4826814 Inhibitors of angiotensin converting enzyme
05/02/1989US4826813 4'-Methyl-β-mercapto-β,β-cyclopentamethylenepropionic acid vasopressin antagonists
05/02/1989US4826811 Crosslinked, pyridoxylated hemoglobin free of tetramers
05/02/1989US4826765 Yeast strains genetically engineered to produce wheat gluten proteins
05/02/1989US4826764 Enhancing the translational initiation frequency of a gene
05/02/1989US4826763 Genetically transformed saccharomyces
04/1989
04/26/1989EP0313515A1 A polypeptide growth factor from milk
04/26/1989EP0313377A1 Process for purification of soluble T4
04/26/1989EP0313343A1 Method of purifying protein
04/26/1989EP0313333A2 Bacterial strain
04/26/1989EP0313224A1 Human cell lines of epithelial lung adenocarcinoma origin, human proteins and methods
04/26/1989EP0313158A2 Gastrin releasing peptide antagonist
04/26/1989EP0313156A1 SnRNP-A antigen and fragments thereof
04/26/1989EP0313104A2 Purification, production and use of tumor necrosis factors
04/26/1989EP0313009A2 Method of gene amplification for enhancing protein production in cultured animal cells
04/26/1989EP0312963A2 Modification method for peptides and proteins
04/26/1989EP0312942A2 Polypeptides with a prourokinase activity, their production and use
04/26/1989EP0312941A2 Polypeptides with a prourokinase activity, their production and use
04/26/1989EP0312898A2 Phenylacetylglutamine (pag) analytical test
04/26/1989EP0312645A1 Antigenic peptides from complement factor C3a, use of peptides, cell lines, antibodies against the peptides and utilisation of the antibodies
04/26/1989EP0312598A1 Peptide functioning to accelerate activation of protein c with thrombin
04/25/1989US4824986 Diethylenetriaminepentaacetic acid substituted with isothiocyanate or n-hydroxysuccinimide
04/25/1989US4824938 Stabilized by maltose-containing polysaccharides
04/25/1989US4824937 Synthetic natriuretic peptides
04/25/1989US4824936 (19-Alanine) calcitonin
04/25/1989US4824850 Dihydropyridine-pyridinium salt redox carrier
04/25/1989US4824659 Antibody conjugates
04/25/1989CA1253299A1 Polypeptide and process for producing the same
04/25/1989CA1253298A1 Synthetic picornavirus antigen
04/25/1989CA1253093A1 Rabies vaccine and preparation process thereof
04/25/1989CA1253092A1 Derivative of the tryptophan operon for expression of fused gene products
04/25/1989CA1253073A1 Antigenic preparations and isolation of such preparations
04/25/1989CA1253071A1 Use of transforming growth factor to promote wound healing
04/25/1989CA1253069A1 Synthetic hepatitis b virus vaccine including both t cell and b cell determinants
04/24/1989EP0302925A4 A method for producing factor viii in high yield.
04/24/1989EP0241539A4 Expression systems for overproduction of desired proteins.
04/20/1989WO1989003532A1 Means for diagnosing arc and aids
04/20/1989WO1989003429A1 Recombinant avipox virus
04/20/1989WO1989003427A1 A method of maintaining a desired recombinant gene in a genetic population of cells
04/20/1989WO1989003423A1 Synthetic dna sequence coding for human insulin-like growth factor ii
04/20/1989WO1989003422A1 Synthetic gene
04/20/1989WO1989003420A1 Anti-retroviral agent
04/20/1989WO1989003399A1 Method of preparation and use for zona pellucida antigens and antibodies for sterilization and contraception
04/20/1989WO1989003398A1 Human monoclonal antibody against candida
04/20/1989WO1989003396A2 Antibodies to natural killer cell and non-specific cytotoxic cell receptor
04/20/1989WO1989003395A1 Receptor for natural killer and non-specific cytotoxic cells
04/20/1989WO1989003394A1 Antigen recognized by natural killer and non-specific cytotoxic cells